SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (2664)9/29/2001 2:07:03 PM
From: nigel batesRead Replies (1) | Respond to of 4974
 
Why the heck didn't they just buy KDUS?

But is it for sale ?

Agreed, their funding execution left a bit to be desired, but in the current environment, it's understandable. After all, their expertise is in protein interactions, and as for the financial guys... we all know about the financial guys.

Genomweb article on funding gives the new conventional wisdom -

genomeweb.com

nig



To: scaram(o)uche who wrote (2664)9/29/2001 3:55:04 PM
From: SpekulatiusRead Replies (1) | Respond to of 4974
 
With TELK offering at 6.5$, I guess i get shot at buying back this stock in the low 5's. Stocks with secondary offerings all have been weak after the offering was closed, probably due to hedging activities of underwriters.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News